1. Home
  2. FTCI vs HBIO Comparison

FTCI vs HBIO Comparison

Compare FTCI & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FTC Solar Inc.

FTCI

FTC Solar Inc.

HOLD

Current Price

$1.63

Market Cap

31.9M

Sector

Technology

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

SELL

Current Price

$8.17

Market Cap

26.5M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
FTCI
HBIO
Founded
2017
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
31.9M
26.5M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
FTCI
HBIO
Price
$1.63
$8.17
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $10.20
N/A
AVG Volume (30 Days)
★ 469.8K
14.6K
Earning Date
11-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
$99,687,000.00
★ $116,176,000.00
Revenue This Year
$38.06
$3.76
Revenue Next Year
$58.28
$5.29
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 110.51
N/A
52 Week Low
$1.62
$0.38
52 Week High
$12.75
$8.80

Technical Indicators

Market Signals
Indicator
FTCI
HBIO
Relative Strength Index (RSI) 28.40 48.08
Support Level N/A $5.91
Resistance Level $2.86 $8.30
Average True Range (ATR) 0.17 0.34
MACD -0.04 -0.05
Stochastic Oscillator 1.39 15.79

Price Performance

Historical Comparison
FTCI
HBIO

About FTCI FTC Solar Inc.

FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S.-manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Share on Social Networks: